Connect to other sites within the UBM Medica Network
Post-Induction PET Predicts Survival in Follicular Lymphoma
A pooled analysis of three prospective trials showed that post-induction therapy PET-CT scans are highly predictive of progression-free and overall survival in follicular lymphoma patients.
PET/MRI Promising for Esophageal Cancer Staging
Preoperative imaging of patients with esophageal cancer by PET and MRI may provide higher accuracy in nodal staging.
PET-CT Does Not Avoid Surgery in Colorectal Cancer Patients
Using PET-CT compared with CT before surgery for potentially resectable liver metastases from colorectal cancer may not significantly alter surgical management.
First Markets to Receive FDA-Approved Amyloid Imaging Agent Announced
GE Healthcare’s Vizamyl, for PET imaging of the brain to estimate beta amyloid neuritic plaque density in cognitively impaired adults, introduced in 7 markets.
FDA Approves Q.Clear by GE for PET/CT Imaging
The FDA has approved GE Healthcare’s Q.Clear, a technology that GE says improves accuracy when assessing a patient’s response to treatment.
Preoperative PET Can Reduce Unnecessary Lung Surgeries
The use of PET imaging in non-small cell lung cancer patients reduced the number of unnecessary surgeries by 50 percent.
PET/MR for Bladder Cancer: UNC Investigates
Could PET/MR be a better modality than conventional MR and CT for bladder cancer?
By clicking Accept, you agree to become a member of the UBM Medica Community.